The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

Share Price Information for Amati Aim Vct (AMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 85.00
Ask: 86.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.176%)
Open: 85.50
High: 85.50
Low: 85.50
Prev. Close: 85.50
AMAT Live PriceLast checked at -
Amati AIM VCT is an Investment Trust

To generate tax free capital gains and regular dividend income, invests primarily in AIM-traded companies and non-qualifying investments as allowed by the VCT legislation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

5 Jun 2020 16:58

RNS Number : 1717P
Amati AIM VCT PLC
05 June 2020
 

Amati AIM VCT plc

Results of Annual General Meeting

 

At the Annual General Meeting of the Company held on Friday 5 June 2020 at 2.00pm, the following resolutions were duly passed.

 

Ordinary Resolutions

1. To receive and adopt the Directors' Report and Financial Statements of the Company for the financial year ended 31 January 2020 together with the Independent Auditor's Report thereon.

 

2. To approve the Directors' Remuneration Policy.

 

3. To approve the Directors' Remuneration Report for the financial year ended 31 January 2020.

 

4. To re-appoint BDO LLP of 150 Aldersgate Street, London, EC1A 4AB as auditor of the Company from the conclusion of the Meeting until the conclusion of the next annual general meeting of the Company to be held in 2021 at which financial statements are laid before the Company.

 

5. To authorise the directors to fix the remuneration of the auditor.

 

6. To re-elect Peter Lawrence as a director of the Company.

 

7. To re-elect Susannah Nicklin as a director of the Company.

 

8. To re-elect Julia Henderson as a director of the Company.

 

9. To re-elect Brian Scouler as a director of the Company.

 

10. THAT, in substitution for all subsisting authorities to the extent unused, the directors of the Company be and are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the "Act"), to exercise all the powers of the Company to allot and issue Ordinary Shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company ("Rights") up to an aggregate nominal value of £1,500,000, provided that:

(i) the authority hereby conferred by this Resolution shall expire (unless previously renewed or revoked) on the earlier of the date of the annual general meeting of the Company to be held in 2021 and the date which is 15 months after the date on which this Resolution is passed;

(ii) the directors may make an offer or agreement which would or might require Ordinary Shares to be allotted, or the Rights are granted, after the authorisation had expired; and

(iii) the directors may allot Ordinary Shares, or grant Rights, under the authority conferred by this Resolution after authorisation has expired if the Ordinary Shares are allotted, or the Rights are granted, in pursuance of an offer or agreement made by the Company before the authorisation expired.

 

Special business

Ordinary Resolution

11. THAT, in accordance with Article 174 of the articles of association of the Company, the continuation of the Company as a venture capital trust be approved.

 

Special Resolutions

12. THAT, subject to the passing of Resolution 10 set out in the Notice of this Meeting and in substitution for any existing authorities, the directors be and hereby are empowered pursuant to sections 570 and 573 of the Act to allot or make offers or agreements to allot equity securities (which expression shall have the meaning ascribed to it in section 560 of the Act) for cash pursuant to the authority given in Resolution 10 set out in the Notice to this Meeting, or by way of sale of treasury shares, as if section 561(1) of the Act did not apply to any such allotment (that is, that the directors' authority to disapply pre-emption rights is

renewed), up to an aggregate nominal amount of £1,500,000. The authority hereby conferred by this Resolution shall expire (unless previously renewed or revoked) on the earlier of the date of the annual general meeting of the Company to be held in 2021 and the date which is 15 months after the date on which this Resolution is passed.

 

13. THAT, in substitution for existing authorities, the Company be and is hereby empowered to make one or more market purchases within the meaning of Section 701 of the Act, of the Ordinary Shares (either for cancellation or for the retention of treasury shares for future re-issue or transfer) provided that:

(i) the maximum aggregate number of Ordinary Shares authorised to be purchased is such number thereof being 14.99 per cent. of the issued ordinary share capital of the Company as at the date of this resolution;

(ii) the minimum price which may be paid per Ordinary Share is 5 pence per share, the nominal amount thereof;

(iii) the maximum price (exclusive of expenses) which may be paid per Ordinary Share is an amount equal to 105 per cent. of the average of the middle market quotation of such Ordinary Share taken from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which such Ordinary Share is to be purchased;

(iv) the authority hereby conferred shall expire on the earlier of the annual general meeting of the Company to be held in 2021 and the date which is 15 months after the date on which this Resolution is passed; and

(v) the Company may make a contract to purchase its own Ordinary Shares under the authority conferred by this Resolution prior to the expiry of such authority which will or may be executed wholly or partly after the expiration of such authority and may make a purchase of such Ordinary Shares pursuant to any such contract.

 

 

Resolution

For & Discretionary

Against

Withheld

1.

Directors' Report and Financial Statements and Auditor's Report

7,413,505

14,336

25,927

2.

Directors' Remuneration Policy

7,019,192

202,879

231,697

3.

Directors' Remuneration Report

6,958,198

230,176

265,394

4.

Re-appoint BDO LLP as auditor

7,176,647

96,173

180,948

5.

Auditor remuneration

7,351,466

37,254

65,048

6.

Re-elect Peter Lawrence

7,208,127

84,006

161,635

7.

Re-elect Susannah Nicklin

7,270,618

40,572

142,578

8.

Re-elect Julia Henderson

7,244,983

66,794

141,991

9.

Re-elect Brian Scouler

7,244,306

50,881

158,581

10.

Allot shares

7,315,601

43,492

94,675

11.

Continuation of Company

7,410,955

32,501

10,312

12.

Authority to disapply pre-emption rights

7,110,641

264,156

78,971

13.

Share buyback authority

7,231,188

175,700

53,267

 

The Company intimated in its Notice of AGM dated 7 May 2020 that its manager Amati Global Investors Limited (the "Manager") would be making available a portfolio update from the Manager to shareholders along with interviews from a selection of the Company's portfolio holdings. The Company is pleased to announce that the presentations from the Manager along with interviews with six of the Company's portfolio investments are now available to view online on the Manager's website at  http://www.amatiglobal.com/videos.php?id=18 , along with an update on the Amati Guildhall Creative Entrepreneurs' Award.

 

For further information please email info@amatiglobal.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGFAMATMTIMBLM
Date   Source Headline
22nd Apr 202411:21 amRNSNet Asset Value(s)
15th Apr 202410:36 amRNSNet Asset Value(s)
12th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 202411:58 amRNSNet Asset Value(s)
3rd Apr 20241:04 pmRNSNet Asset Value(s)
3rd Apr 202412:15 pmRNSTransaction in Own Shares
2nd Apr 202411:06 amRNSTotal Voting Rights
25th Mar 20242:26 pmRNSTransaction in Own Shares
25th Mar 202412:39 pmRNSNet Asset Value(s)
18th Mar 20241:55 pmRNSNet Asset Value(s)
15th Mar 20243:00 pmRNSTransaction in Own Shares
14th Mar 20245:11 pmRNSCompliance with Market Abuse Regulation
14th Mar 20247:00 amRNSStrategic Review
11th Mar 202410:12 amRNSNet Asset Value(s)
4th Mar 20249:55 amRNSNet Asset Value(s)
1st Mar 20244:18 pmRNSTotal Voting Rights
29th Feb 20242:27 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSNet Asset Value(s)
19th Feb 202410:21 amRNSNet Asset Value(s)
14th Feb 20244:36 pmRNSTransaction in Own Shares
9th Feb 20244:56 pmRNSNet Asset Value(s)
2nd Feb 20246:03 pmRNSTransaction in Own Shares
2nd Feb 202412:15 pmRNSNet Asset Value(s)
1st Feb 20242:21 pmRNSTotal Voting Rights
29th Jan 202411:53 amRNSNet Asset Value(s)
26th Jan 20245:14 pmRNSTransaction in Own Shares
19th Jan 20245:03 pmRNSNet Asset Value(s)
16th Jan 20244:34 pmRNSTransaction in Own Shares
15th Jan 20244:20 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20242:51 pmRNSNet Asset Value(s)
5th Jan 20245:29 pmRNSNet Asset Value(s)
3rd Jan 202412:44 pmRNSNet Asset Value(s)
2nd Jan 20241:58 pmRNSTotal Voting Rights
21st Dec 20233:45 pmRNSNet Asset Value(s)
20th Dec 20233:56 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 202311:01 amRNSNet Asset Value(s)
4th Dec 202310:44 amRNSNet Asset Value(s)
1st Dec 202310:25 amRNSTotal Voting Rights
30th Nov 20234:02 pmRNSDividend Declaration
28th Nov 202312:46 pmRNSTransaction in Own Shares
27th Nov 202312:16 pmRNSDirector/PDMR Shareholding
27th Nov 20239:34 amRNSIssue of Equity
24th Nov 20234:23 pmRNSNet Asset Value(s)
20th Nov 202310:19 amRNSNet Asset Value(s)
17th Nov 20234:46 pmRNSTransaction in Own Shares
13th Nov 20239:31 amRNSNet Asset Value(s)
6th Nov 202312:27 pmRNSTransaction in Own Shares
2nd Nov 20239:34 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.